Page 385 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 385
Chapter 26 Biology of Erythropoiesis, Erythroid Differentiation, and Maturation 320.e1
REFERENCES SCF-controlled protection against TRAIL in erythroid progenitors. J
Exp Med 199:785, 2004.
1. Shivdasani RA, Orkin SH: The transcriptional control of hematopoi- 27. van den Akker E, van Dijk TB, Schmidt U, et al: The Btk inhibitor
esis. Blood 87:4025, 1996. LFM-A13 is a potent inhibitor of Jak2 kinase activity. Biol Chem
2. Cantor AB, Orkin SH: Transcriptional regulation of erythropoiesis: an 385:409, 2004.
affair involving multiple partners. Oncogene 21:3368, 2002. 28. Mirandola P, Gobbi G, Ponti C, et al: PKCepsilon controls protection
3. Morrison SJ, Shah NM, Anderson DJ: Regulatory mechanisms in stem against TRAIL in erythroid progenitors. Blood 107:508, 2006.
cell biology. Cell 88:287, 1997. 29. Silvestris F, Cafforio P, Tucci M, et al: Negative regulation of erythro-
4. Enver T, Greaves M: Loops, lineage, and leukemia. Cell 94:9, 1998. blast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells:
5. Ogawa M, Porter PN, Nakahata T: Renewal and commitment to dif- a major pathogenetic mechanism of anemia in multiple myeloma. Blood
ferentiation of hemopoietic stem cells (an interpretive review). Blood 99:1305, 2002.
61:823, 1983. 30. Claessens YE, Park S, Dubart-Kupperschmitt A, et al: Rescue of
6. Fairbairn LJ, Cowling GJ, Reipert BM, et al: Suppression of apoptosis early-stage myelodysplastic syndrome-deriving erythroid precursors by
allows differentiation and development of a multipotent hemopoietic the ectopic expression of a dominant-negative form of FADD. Blood
cell line in the absence of added growth factors. Cell 74:823, 1993. 105:4035, 2005.
7. Hu M, Krause D, Greaves M, et al: Multilineage gene expression 31. Choi SJ, Moon JH, Ahn YW, et al: Tsc-22 enhances TGF-beta signaling
precedes commitment in the hemopoietic system. Genes Dev 11:774, by associating with Smad4 and induces erythroid cell differentiation.
1997. Mol Cell Biochem 271:23, 2005.
8. Miyamoto T, Iwasaki H, Reizis B, et al: Myeloid or lymphoid promis- 32. Thawani N, Tam M, Chang KH, et al: Interferon-gamma mediates
cuity as a critical step in hematopoietic lineage commitment. Dev Cell suppression of erythropoiesis but not reduced red cell survival following
3:137, 2002. CpG-ODN administration in vivo. Exp Hematol 34:1451, 2006.
9. Testa NG: Structure and regulation of the erythroid system at the level 33. Libregts SF, Gutierrez L, de Bruin AM, et al: Chronic IFN-gamma
of progenitor cells. Crit Rev Oncol Hematol 9:17, 1989. production in mice induces anemia by reducing erythrocyte life span
10. Akashi K, Traver D, Miyamoto T, et al: A clonogenic common myeloid and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood
progenitor that gives rise to all myeloid lineages. Nature 404:193, 2000. 118:2578, 2011.
11. Manz MG, Miyamoto T, Akashi K, et al: Prospective isolation of 34. Babitt JL, Huang FW, Wrighting DM, et al: Bone morphogenetic
human clonogenic common myeloid progenitors. Proc Natl Acad Sci protein signaling by hemojuvelin regulates hepcidin expression. Nat
USA 99:11872, 2002. Genet 38:531, 2006.
12. Yokochi T, Brice M, Rabinovitch PS, et al: Monoclonal antibodies 35. Roy CN, Mak HH, Akpan I, et al: Hepcidin antimicrobial peptide
detecting antigenic determinants with restricted expression on erythroid transgenic mice exhibit features of the anemia of inflammation. Blood
cells: from the erythroid committed progenitor level to the mature 109:4038, 2007.
erythroblast. Blood 63:1376, 1984. 36. Dallalio G, Law E, Means RT, Jr: Hepcidin inhibits in vitro erythroid
13. Das Gupta A, Samoszuk MK, Papayannopoulou T, et al: SFL 23.6: a colony formation at reduced erythropoietin concentrations. Blood
monoclonal antibody reactive with CFU-E, erythroblasts, and erythro- 107:2702, 2006.
cytes. Blood 66:522, 1985. 37. Kautz L, Jung G, Valore EV, et al: Identification of erythroferrone as
14. Abkowitz JL, Holly RD, Hammond WPt: Cyclic hematopoiesis in an erythroid regulator of iron metabolism. Nat Genet 46:678, 2014.
dogs: studies of erythroid burst-forming cells confirm an early stem cell 38. Kautz L, Jung G, Nemeth E, et al: Erythroferrone contributes to
defect. Exp Hematol 16:941, 1988. recovery from anemia of inflammation. Blood 124:2569, 2014.
15. Iscove NN, Guilbert LJ, Weyman C: Complete replacement of serum 39. To LB, Haylock DN, Simmons PJ, et al: The biology and clinical uses
in primary cultures of erythropoietin-dependent red cell precursors of blood stem cells. Blood 89:2233, 1997.
(CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin 40. Papayannopoulou T: Current mechanistic scenarios in hematopoietic
and cholesterol. Exp Cell Res 126:121, 1980. stem/progenitor cell mobilization. Blood 103:1580, 2004.
16. Sonoda Y, Ogawa M: Serum-free culture of human hemopoietic 41. Flomenberg N, Devine SM, Dipersio JF, et al: The use of AMD3100
progenitors in attenuated culture media. Am J Hematol 28:227, 1988. plus G-CSF for autologous hematopoietic progenitor cell mobilization
17. Rich IN, Kubanek B: The effect of reduced oxygen tension on colony is superior to G-CSF alone. Blood 106:1867, 2005.
formation of erythropoietic cells in vitro. Br J Haematol 52:579, 1982. 42. Migliaccio G, Migliaccio AR, Druzin ML, et al: Long-term generation
18. Clark SC, Kamen R: The human hematopoietic colony-stimulating of colony-forming cells in liquid culture of CD34+ cord blood cells in
factors. Science 236:1229, 1987. the presence of recombinant human stem cell factor. Blood 79:2620,
19. Bernstein A, Forrester L, Reith AD, et al: The murine W/c-kit and Steel 1992.
loci and the control of hematopoiesis. Semin Hematol 28:138, 1991. 43. Fibach E, Manor D, Oppenheim A, et al: Proliferation and maturation
20. Kaushansky K: Thrombopoietin: the primary regulator of platelet of human erythroid progenitors in liquid culture. Blood 73:100, 1989.
production. Blood 86:419, 1995. 44. Ziegler BL, Muller R, Valtieri M, et al: Unicellular-unilineage eryth-
21. Park LS, Waldron PE, Friend D, et al: Interleukin-3, GM-CSF, and ropoietic cultures: molecular analysis of regulatory gene expression at
G-CSF receptor expression on cell lines and primary leukemia cells: sibling cell level. Blood 93:3355, 1999.
receptor heterogeneity and relationship to growth factor responsiveness. 45. Migliaccio G, Di Pietro R, di Giacomo V, et al: In vitro mass produc-
Blood 74:56, 1989. tion of human erythroid cells from the blood of normal donors and of
22. Leary AG, Ogawa M: Blast cell colony assay for umbilical cord blood thalassemic patients. Blood Cells Mol Dis 28:169, 2002.
and adult bone marrow progenitors. Blood 69:953, 1987. 46. von Lindern M, Zauner W, Mellitzer G, et al: The glucocorticoid recep-
23. Keller JR, Mantel C, Sing GK, et al: Transforming growth factor beta tor cooperates with the erythropoietin receptor and c-Kit to enhance
1 selectively regulates early murine hematopoietic progenitors and and sustain proliferation of erythroid progenitors in vitro. Blood 94:550,
inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J 1999.
Exp Med 168:737, 1988. 47. Leberbauer C, Boulme F, Unfried G, et al: Different steroids co-regulate
24. Broxmeyer HE, Williams DE: The production of myeloid blood cells long-term expansion versus terminal differentiation in primary human
and their regulation during health and disease. Crit Rev Oncol Hematol erythroid progenitors. Blood 105:85, 2005.
8:173, 1988. 48. Mohandas N: Banking on red blood cells. Nat Biotechnol 23:35, 2005.
25. Zamai L, Secchiero P, Pierpaoli S, et al: TNF-related apoptosis-inducing 49. Migliaccio AR, Whitsett C, Migliaccio G: Erythroid cells in vitro:
ligand (TRAIL) as a negative regulator of normal human erythropoiesis. from developmental biology to blood transfusion products. Curr Opin
Blood 95:3716, 2000. Hematol 16:259, 2009.
26. Schmidt U, van den Akker E, Parren-van Amelsvoort M, et al: 50. Masiello F, Tirelli V, Sanchez M, et al: Mononuclear cells from a
Btk is required for an efficient response to erythropoietin and for rare blood donor, after freezing under good manufacturing practice

